Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Our committees
Who we are
What we do
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Accessing medicines
›
One Wales Medicines process
›
One Wales medicine assessment documents
›
OW04 documents
OW04 documents
23/04/2024
Fourth review: adalimumab (OW04) One Wales Interim Decision and evidence review Jul 21
23/04/2024
First review: adalimumab (OW04) One Wales Interim Decision and evidence review Nov 17
23/04/2024
Original assessment: adalimumab (OW04) Evidence Status Report Nov 16
23/04/2024
Fifth review: adalimumab (OW04) One Wales Interim Decision and evidence review Dec 23
23/04/2024
Third review: adalimumab (OW04) One Wales Interim decision and evidence review Jul 20
23/04/2024
Second review: adalimumab (OW04) One Wales Interim decision and evidence review Jan 19
23/04/2024
Original assessment: adalimumab (OW04) One Wales Interim Decision Nov 16
Follow AWTTC:
